US Markets

Health Care Sector Update for 07/16/2020: TCDA, TLSA, ABT, XLV, IBB

Health care firms were slipping premarket Thursday as the Health Care SPDR (XLV) was down 0.2% and the iShares NASDAQ Biotechnology Index (IBB) was 0.8% lower recently.

Tricida (TCDA) declined by more than 33% after saying the US Food and Drug Administration has found deficiencies in its new drug application for veverimer to treat metabolic acidosis in patients with chronic kidney disease.

Tiziana Life Sciences (TLSA) retreated more than 4%. The company said Thursday it has submitted a patent application on the potential use of the anti-CD3 monoclonal antibody Foralumab to improve the effectiveness of CAR-T therapy in cancer and other diseases.

Meanwhile, Abbott (ABT) gained 1% after reporting on Thursday Q2 adjusted EPS of $0.57, down from $0.82 a year earlier, but higher than the $0.42 average estimate of analysts surveyed by Capital IQ.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

TCDA TLSA ABT XLV IBB

Latest Markets Videos

    MTNewswires

    Founded in 1999, MT Newswires (formerly known as Midnight Trader) is a leading provider of original source, multi-asset class, real-time, global financial news and information to most of the largest banks, brokerage firms and professional market data, trading & research applications in North America.

    Learn More